Evidence map›Paper›PMID 32810225›Full record

ArticleEndocrinology2020

Differentiation of PTH-Expressing Cells From Human Pluripotent Stem Cells.

Betty R Lawton, Corine Martineau, Julie Ann Sosa, Sanziana Roman, Courtney E Gibson, Michael A Levine, Diane S Krause

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Advances in Parathyroid Hormone-based medicines.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Parathyroid Gland Generation from Pluripotent Stem Cells.Endocrinology and metabolism (Seoul, Korea) · 2024
    Review
  8. Article
  9. Article
  10. Functional calcium-responsive parathyroid glands generated using single-step blastocyst complementation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Betty R LawtonDepartment of Laboratory Medicine, Yale Stem Cell Center, Yale University, New Haven, Connecticut.
Corine MartineauCenter for Bone Health and Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Julie Ann SosaDepartment of Surgery, University of California San Francisco, San Francisco, California.
Sanziana RomanDepartment of Surgery, University of California San Francisco, San Francisco, California.
Courtney E GibsonDepartment of Surgery, Yale University, New Haven, Connecticut.
Michael A LevineCenter for Bone Health and Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Diane S KrauseDepartment of Laboratory Medicine, Cell Biology, Yale Stem Cell Center, Yale University, New Haven, Connecticut.
Children's Hospital of Philadelphia · USUniversity of California, San Francisco · USYale Cancer Center · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
"Exploration of Human Parathyroid Cellular Organization and Function"R21CA240660 · NCI · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2020 to 2020
$431k
NCATS NIH HHS UL1 TR001863NCI NIH HHS R21 CA240660
6 · The paper itself

Abstract

Differentiation of pluripotent stem cells into functional parathyroid-like cells would accelerate development of important therapeutic options for subjects with parathyroid-related disorders, from the design and screening of novel pharmaceutical agents to the development of durable cellular therapies. We have established a highly reproducible directed differentiation approach leading to PTH-expressing cells from human embryonic stem cells and induced pluripotent stem cells. We accomplished this through the comparison of multiple different basal media, the inclusion of the CDK inhibitor PD0332991 in both definitive endoderm and anterior foregut endoderm stages, and a 2-stage pharyngeal endoderm series. This is the first protocol to reproducibly establish PTH-expressing cells from human pluripotent stem cells and represents a first step toward the development of functional parathyroid cells with broad applicability for medicinal and scientific investigation.

Indexed as

Cell DifferentiationCells, CulturedEndodermGene Expression Regulation, DevelopmentalHuman Embryonic Stem CellsHumansOrganogenesisParathyroid GlandsParathyroid HormonePluripotent Stem CellsParathyroid HormonePTH protein, humancalciumdevelopmenthypoparathyroidismregenerative medicinestem cells

Identifiers

PMID32810225
PMCPMC7505176
OpenAlexW3072699768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.